These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21482004)

  • 1. [Relative validity of the 10-year cardiovascular risk estimate in a population cohort of the REGICOR study].
    Marrugat J; Vila J; Baena-Díez JM; Grau M; Sala J; Ramos R; Subirana I; Fitó M; Elosua R
    Rev Esp Cardiol; 2011 May; 64(5):385-94. PubMed ID: 21482004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation and validation of a set of 10-year cardiovascular risk predictive functions in Spain: the FRESCO Study.
    Marrugat J; Subirana I; Ramos R; Vila J; Marín-Ibañez A; Guembe MJ; Rigo F; Tormo Díaz MJ; Moreno-Iribas C; Cabré JJ; Segura A; Baena-Díez JM; de la Cámara AG; Lapetra J; Grau M; Quesada M; Medrano MJ; González Diego P; Frontera G; Gavrila D; Aicua EA; Basora J; García JM; García-Lareo M; Gutierrez JA; Mayoral E; Sala J; D'Agostino R; Elosua R;
    Prev Med; 2014 Apr; 61():66-74. PubMed ID: 24412897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.
    Riddell T; Wells S; Jackson R; Lee AW; Crengle S; Bramley D; Ameratunga S; Pylypchuk R; Broad J; Marshall R; Kerr A
    N Z Med J; 2010 Feb; 123(1309):50-61. PubMed ID: 20186242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estimating cardiovascular risk in Spain using different algorithms].
    Comín E; Solanas P; Cabezas C; Subirana I; Ramos R; Gené-Badía J; Cordón F; Grau M; Cabré-Vila JJ; Marrugat J
    Rev Esp Cardiol; 2007 Jul; 60(7):693-702. PubMed ID: 17663853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study.
    Marrugat J; Subirana I; Comín E; Cabezas C; Vila J; Elosua R; Nam BH; Ramos R; Sala J; Solanas P; Cordón F; Gené-Badia J; D'Agostino RB;
    J Epidemiol Community Health; 2007 Jan; 61(1):40-7. PubMed ID: 17183014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk functions incorporated in Riscard 2002: a software for the prediction of cardiovascular risk in the general population based on Italian data.
    Menotti A; Lanti M; Puddu PE; Carratelli L; Mancini M; Motolese M; Prati P; Zanchetti A
    Ital Heart J; 2002 Feb; 3(2):114-21. PubMed ID: 11926009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk prediction of incident coronary heart disease in The Netherlands: re-estimation and improvement of the SCORE risk function.
    Merry AH; Boer JM; Schouten LJ; Ambergen T; Steyerberg EW; Feskens EJ; Verschuren WM; Gorgels AP; van den Brandt PA
    Eur J Prev Cardiol; 2012 Aug; 19(4):840-8. PubMed ID: 21551214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Framingham Heart Study risk equation predicts first cardiovascular event rates in New Zealanders at the population level.
    Milne R; Gamble G; Whitlock G; Jackson R
    N Z Med J; 2003 Nov; 116(1185):U662. PubMed ID: 14615804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Riskard 2005. New tools for prediction of cardiovascular disease risk derived from Italian population studies.
    Menotti A; Lanti M; Agabiti-Rosei E; Carratelli L; Cavera G; Dormi A; Gaddi A; Mancini M; Motolese M; Muiesan ML; Muntoni S; Muntoni S; Notarbartolo A; Prati P; Remiddi S; Zanchetti A
    Nutr Metab Cardiovasc Dis; 2005 Dec; 15(6):426-40. PubMed ID: 16314229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona.
    Herrera S; Guelar A; Sorlì L; Vila J; Molas E; Grau M; Marrugat J; Esteve E; Güerri-Fernández R; Montero M; Knobel H
    HIV Clin Trials; 2016 Jul; 17(4):131-9. PubMed ID: 27169692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should pulse pressure become part of the Framingham risk score?
    Nawrot TS; Staessen JA; Thijs L; Fagard RH; Tikhonoff V; Wang JG; Franklin SS
    J Hum Hypertens; 2004 Apr; 18(4):279-86. PubMed ID: 15037878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-specific threshold levels of plasma B-type natriuretic peptide for prediction of cardiovascular event risk in a Japanese population initially free of cardiovascular disease.
    Nakamura M; Tanaka F; Takahashi T; Makita S; Ishisone T; Onodera M; Ishibashi Y; Itai K; Onoda T; Ohsawa M; Tanno K; Sakata K; Shinichi O; Ogasawara K; Ogawa A; Kuribayashi T; Okayama A
    Am J Cardiol; 2011 Dec; 108(11):1564-9. PubMed ID: 21871591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The global cardiovascular risk chart].
    Giampaoli S; Palmieri L; Chiodini P; Cesana G; Ferrario M; Panico S; Pilotto L; Sega R; Vanuzzo D;
    Ital Heart J Suppl; 2004 Mar; 5(3):177-85. PubMed ID: 15116861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the REGICOR and SCORE function charts for classifying cardiovascular risk and for selecting patients for hypolipidemic or antihypertensive treatment].
    Buitrago F; Cañón-Barroso L; Díaz-Herrera N; Cruces-Muro E; Escobar-Fernández M; Serrano-Arias JM
    Rev Esp Cardiol; 2007 Feb; 60(2):139-47. PubMed ID: 17338879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison and agreement of the Cockcroft-Gault and MDRD equations to estimate glomerular filtration rate in diagnosis of occult chronic kidney disease].
    Buitrago F; Calvo JI; Gómez-Jiménez C; Cañón L; Robles NR; Angulo E
    Nefrologia; 2008; 28(3):301-10. PubMed ID: 18590497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study.
    Khalili D; Hadaegh F; Soori H; Steyerberg EW; Bozorgmanesh M; Azizi F
    Am J Epidemiol; 2012 Aug; 176(3):177-86. PubMed ID: 22814370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Validation and generalizability of the predictive model of ischemic cardiovascular diseases in Chinese].
    Li X; Zhao LC; Li Y; Zhang LF; Zhou BF; Wu YF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Aug; 35(8):761-4. PubMed ID: 17963640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk prediction tools for populations in Asia.
    ; Barzi F; Patel A; Gu D; Sritara P; Lam TH; Rodgers A; Woodward M
    J Epidemiol Community Health; 2007 Feb; 61(2):115-21. PubMed ID: 17234869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.